semaglutide vs fasting Choosing Oral vs. Injectable for Weight Loss How to Fast Safely on

TripleHormoneReceptor Agonist Retatrutide in Adults with Obesity

Meng et al., 2024)

The market for semaglutide API is expanding as long as regulatory agencies continue to encourage novel therapies for diabetes and obesity

Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have proven remarkably effective at helping patients lose weight

DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) like sitagliptin, linagliptin, or saxagliptin provide moderate glucose-lowering with minimal gastrointestinal side effects and are weight-neutral